Minerva Surgical, Inc. (UTRS)
| Market Cap | 888.00 +897.8% |
| Revenue (ttm) | 51.69M +3.1% |
| Net Income | -33.45M |
| EPS | -5.38 |
| Shares Out | 8.88M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 204 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.000001 - 0.0010 |
| Beta | 150.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |
About Minerva Surgical
Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities. It also offers Resectr, a tissue resection device to diagnose and treat polyps... [Read more]
News
Minerva Surgical price target lowered to $3 from $20 at Piper Sandler
Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Minerva Surgical to $3 from $20, adjusted for the 1-for-20 reverse stock split, and keeps an Overweight rating on…
Minerva Surgical Quarterly report: Q3 2023
Minerva Surgical has published its Q3 2023 quarterly earnings report on November 13, 2023.
Minerva Surgical Earnings release: Q3 2023
Minerva Surgical released its Q3 2023 earnings on November 13, 2023, summarizing the period's financial results.
Minerva Surgical Reports Third Quarter 2023 Financial Results
SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uteri...
Minerva Surgical Earnings Call Transcript: Q2 2023
Minerva Surgical Quarterly report: Q2 2023
Minerva Surgical has published its Q2 2023 quarterly earnings report on August 2, 2023.
Minerva Surgical Earnings release: Q2 2023
Minerva Surgical released its Q2 2023 earnings on August 2, 2023, summarizing the period's financial results.
Minerva Surgical Reports Second Quarter 2023 Financial Results
SANTA CLARA, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uteri...
Minerva Surgical price target lowered to $1 from $5 at Piper Sandler
Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Minerva Surgical to $1 from $5 and keeps an Overweight rating on the shares following the Q1 sales beat.
Minerva Surgical Earnings Call Transcript: Q1 2023
Minerva Surgical Quarterly report: Q1 2023
Minerva Surgical has published its Q1 2023 quarterly earnings report on May 2, 2023.
Minerva Surgical Earnings release: Q1 2023
Minerva Surgical released its Q1 2023 earnings on May 2, 2023, summarizing the period's financial results.
Minerva Surgical Reports First Quarter 2023 Financial Results
SANTA CLARA, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterin...
Minerva Surgical to Announce First Quarter 2023 Financial Results
SANTA CLARA, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a medical technology company focused on solutions to meet the distinct uterine healthcare needs of women,...
Minerva Surgical Earnings Call Transcript: Q4 2022
Minerva Surgical Annual report: Q4 2022
Minerva Surgical has published its Q4 2022 annual report on March 21, 2023.
Minerva Surgical Earnings release: Q4 2022
Minerva Surgical released its Q4 2022 earnings on March 21, 2023, summarizing the period's financial results.
Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer
SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical), a women's health company focused on solutions to meet the distinct uterine healthcare ...
Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results
SANTA CLARA, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on solutions to meet the distinct uter...
Minerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial Results
SANTA CLARA, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today tha...
Hologic announces U.S. Court of Appeals affirmation of 2021 ruling against Minerva Surgical
Hologic (HOLX) announced that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a 2021 district court ruling that invalidated a Minerva (UTRS) patent asserted against Hologic. The...
Minerva Surgical Closes $30 Million Private Placement of Common Stock
SANTA CLARA, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bl...
Minerva Surgical Transcript: JPMorgan Healthcare Conference
Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference
SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on the treatment of Abnormal Uterine Bl...
Minerva Surgical CEO David Clapper to retire
Minerva Surgica "announced that David Clapper, who has served as President and CEO since 2011, has chosen to retire. The Company’s board of directors has appointed industry executive Todd Usen…